These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 28186867)

  • 1. Significant Improvement in Cognition in Mild to Moderately Severe Dementia Cases Treated with Transcranial Plus Intranasal Photobiomodulation: Case Series Report.
    Saltmarche AE; Naeser MA; Ho KF; Hamblin MR; Lim L
    Photomed Laser Surg; 2017 Aug; 35(8):432-441. PubMed ID: 28186867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Home Photobiomodulation Treatments on Cognitive and Behavioral Function, Cerebral Perfusion, and Resting-State Functional Connectivity in Patients with Dementia: A Pilot Trial.
    Chao LL
    Photobiomodul Photomed Laser Surg; 2019 Mar; 37(3):133-141. PubMed ID: 31050950
    [No Abstract]   [Full Text] [Related]  

  • 3. Rapid Reversal of Cognitive Decline, Olfactory Dysfunction, and Quality of Life Using Multi-Modality Photobiomodulation Therapy: Case Report.
    Salehpour F; Hamblin MR; DiDuro JO
    Photobiomodul Photomed Laser Surg; 2019 Mar; 37(3):159-167. PubMed ID: 31050946
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of Neurodegeneration: Integrating Photobiomodulation and Neurofeedback in Alzheimer's Dementia and Parkinson's: A Review.
    Berman MH; Nichols TW
    Photobiomodul Photomed Laser Surg; 2019 Oct; 37(10):623-634. PubMed ID: 31647776
    [No Abstract]   [Full Text] [Related]  

  • 5. A Randomized, Double-Blind, and Sham-Controlled Trial of an Innovative Brain-Gut Photobiomodulation Therapy: Safety and Patient Compliance.
    Blivet G; Relano-Gines A; Wachtel M; Touchon J
    J Alzheimers Dis; 2022; 90(2):811-822. PubMed ID: 36189591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translation from Preclinical Research to Clinical Trials: Brain-Gut Photobiomodulation Therapy for Alzheimer's Disease.
    Blivet G; Roman FJ; Delrieu J; Touchon J
    J Integr Neurosci; 2024 Mar; 23(3):57. PubMed ID: 38538226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased Functional Connectivity Within Intrinsic Neural Networks in Chronic Stroke Following Treatment with Red/Near-Infrared Transcranial Photobiomodulation: Case Series with Improved Naming in Aphasia.
    Naeser MA; Ho MD; Martin PI; Hamblin MR; Koo BB
    Photobiomodul Photomed Laser Surg; 2020 Feb; 38(2):115-131. PubMed ID: 31621498
    [No Abstract]   [Full Text] [Related]  

  • 8. Gut flora-targeted photobiomodulation therapy improves senile dementia in an Aß-induced Alzheimer's disease animal model.
    Chen Q; Wu J; Dong X; Yin H; Shi X; Su S; Che B; Li Y; Yang J
    J Photochem Photobiol B; 2021 Mar; 216():112152. PubMed ID: 33610085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reported Side Effects, Weight and Blood Pressure, After Repeated Sessions of Transcranial Photobiomodulation.
    Cassano P; Caldieraro MA; Norton R; Mischoulon D; Trinh NH; Nyer M; Dording C; Hamblin MR; Campbell B; Iosifescu DV
    Photobiomodul Photomed Laser Surg; 2019 Oct; 37(10):651-656. PubMed ID: 31647774
    [No Abstract]   [Full Text] [Related]  

  • 10. Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial.
    De Jesus Moreno Moreno M
    Clin Ther; 2003 Jan; 25(1):178-93. PubMed ID: 12637119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nutritional Ketosis and photobiomodulation remediate mitochondria warding off Alzheimer's disease in a diabetic, ApoE4+ patient with mild cognitive impairment: A case report.
    Horner S; Berger L; Gibas K
    Photodiagnosis Photodyn Ther; 2020 Jun; 30():101777. PubMed ID: 32305654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosimetry and Clinical Efficacy of Transcranial Photobiomodulation for Major Depression Disorder: Could they Guide Dosimetry for Alzheimer's Disease?
    Caldieraro MA; Laufer-Silva T; Cassano P
    J Alzheimers Dis; 2021; 83(4):1453-1469. PubMed ID: 34487045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of placebo group decline in the Alzheimer's disease Assessment Scale-cognitive subscale (ADAS-Cog) in 24 week clinical trials of Alzheimer's disease.
    Irizarry MC; Webb DJ; Bains C; Barrett SJ; Lai RY; Laroche JP; Hosford D; Maher-Edwards G; Weil JG
    J Alzheimers Dis; 2008 Jul; 14(3):301-11. PubMed ID: 18599956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation study of the Alzheimer's disease assessment scale-cognitive subscale (ADAS-Cog) for the Portuguese patients with mild cognitive impairment and Alzheimer's disease.
    Nogueira J; Freitas S; Duro D; Almeida J; Santana I
    Clin Neuropsychol; 2018; 32(sup1):46-59. PubMed ID: 29566598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcranial Photobiomodulation with Near-Infrared Light for Generalized Anxiety Disorder: A Pilot Study.
    Maiello M; Losiewicz OM; Bui E; Spera V; Hamblin MR; Marques L; Cassano P
    Photobiomodul Photomed Laser Surg; 2019 Oct; 37(10):644-650. PubMed ID: 31647775
    [No Abstract]   [Full Text] [Related]  

  • 16. Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia: A Randomized Clinical Trial.
    Craft S; Raman R; Chow TW; Rafii MS; Sun CK; Rissman RA; Donohue MC; Brewer JB; Jenkins C; Harless K; Gessert D; Aisen PS
    JAMA Neurol; 2020 Sep; 77(9):1099-1109. PubMed ID: 32568367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender Differences of Dementia in Response to Intensive Self-Administered Transcranial and Intraocular Near-Infrared Stimulation.
    Qi X; Nizamutdinov D; Berman MH; Dougal G; Chazot PL; Wu E; Stevens AB; Yi SS; Huang JH
    Cureus; 2021 Jul; 13(7):e16188. PubMed ID: 34262831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photobiomodulation's potential as a non-invasive therapy for alzheimer's disease and minimal cognitive impairment: A 12-week investigation.
    Razzaghi M; Sheibani F; Kimia N; Razzaghi Z; Chenari Z; Ashrafi F; Barati M; Advani S
    Photodiagnosis Photodyn Ther; 2024 Apr; 46():103991. PubMed ID: 38367922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protocol Report on the Transcranial Photobiomodulation for Alzheimer's Disease (TRAP-AD) Study.
    Iosifescu DV; Song X; Gersten MB; Adib A; Cho Y; Collins KM; Yates KF; Hurtado-Puerto AM; McEachern KM; Osorio RS; Cassano P
    Healthcare (Basel); 2023 Jul; 11(14):. PubMed ID: 37510458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized, sham-controlled, clinical trial of repetitive transcranial magnetic stimulation for patients with Alzheimer's dementia in Japan.
    Saitoh Y; Hosomi K; Mano T; Takeya Y; Tagami S; Mori N; Matsugi A; Jono Y; Harada H; Yamada T; Miyake A
    Front Aging Neurosci; 2022; 14():993306. PubMed ID: 36313021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.